⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABBV News
ABBVIE INC.
FDA clears Healis Therapeutics’ IND for Tyemvers®, Enabling U.S. Neuropsychiatric Trials
globenewswire.com
ABBV
Allergan Aesthetics Announces U.S. FDA Acceptance of Supplemental Biologics License Application for BOTOX® Cosmetic for Masseter Muscle Prominence
prnewswire.com
ABBV
Form 8-K
sec.gov
ABBV
AbbVie Reports Second-Quarter 2026 Financial Results
prnewswire.com
ABBV
Continuity Biosciences beruft Vicky Papoutsis in den Vorstand
prnewswire.com
ABBV
Apogee Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apogee Therapeutics, Inc. - APGE
businesswire.com
ABBV
APGE
Inflammatory Bowel Disease Market to Experience Strong Uptake During the Forecast Period (2026-2036), Driven by Development of Next-generation Therapies Targeting IL-23, TL1A, and S1P Pathways | DelveInsight
prnewswire.com
JNJ
MRK
TEVA
LLY
ABBV
PFE
AZN
Continuity Biosciences nombra a Vicky Papoutsis miembro de su consejo de administración
prnewswire.com
ABBV
Continuity Biosciences nomme Vicky Papoutsis au conseil d'administration
prnewswire.com
ABBV
DIS
JUVÉDERM® Day Returns to U.S. on August 19
prnewswire.com
ABBV